Consortium for Optimized Integration of Bio-Artificial Blood Components for Adaptive Resuscitation Therapy

Launched by UNIVERSITY OF MARYLAND, BALTIMORE · Feb 23, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new type of artificial blood that could help save lives in emergencies when regular blood is not available or suitable. The goal is to create a product that works like whole blood by combining different artificial components that mimic the functions of oxygen carriers, plasma, and platelets. This new blood substitute aims to improve treatment for patients experiencing severe bleeding, whether in civilian situations like trauma or on the battlefield. By developing this product, researchers hope to provide better care during the critical time right after an injury.

To participate in this trial, you need to be at least 18 years old, weigh more than 88 pounds, and generally be in good health. Unfortunately, people with infections, pregnant individuals, or those who do not speak English are not eligible to join. If you decide to participate, you will help test the effectiveness of this artificial blood in a controlled setting, which could lead to better outcomes for patients facing life-threatening bleeding in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subject \>/= 18 years of age
• • Subject weighs \>40kg (88lbs)
• • Subject must be generally healthy
• Exclusion Criteria:
• • Suspected or diagnosed with ongoing (chronic) or acute infection
• • Subject is pregnant
• • Subject is non-english speaking